Phase II Study of Eribulin Mesylate, a Halichondrin B...

Journal of Clinical Oncology 2009 / 06 Vol. 27; Iss. 18

Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

Vahdat, L. T., Pruitt, B., Fabian, C. J., Rivera, R. R., Smith, D. A., Tan-Chiu, E., Wright, J., Tan, A. R., DaCosta, N. A., Chuang, E., Smith, J., O'Shaughnessy, J., Shuster, D. E., Meneses, N. L., C
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2008.17.7618
Date:
June, 2009
File:
PDF, 146 KB
english, 2009
Conversion to is in progress
Conversion to is failed